Back to BMRN
DODGE & COX BMRN Position History
BioMarin Pharmaceutical Inc. • Healthcare
Quarters held
15
Latest value
$849.4M
Q2 2026
Peak value
$1.4B
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $1.4B |
| Q2 2023 | $1.2B |
| Q3 2023 | $1.3B |
| Q4 2023 | $1.3B |
| Q4 2023 | $1.3B |
| Q1 2024 | $1.2B |
| Q2 2024 | $1.1B |
| Q3 2024 | $976.9M |
| Q4 2024 | $969.3M |
| Q1 2025 | $1.1B |
| Q2 2025 | $830.5M |
| Q3 2025 | $795.4M |
| Q4 2025 | $866M |
| Q1 2026 | $822.6M |
| Q2 2026 | $849.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $849.4M | 14.84M | — | — |
| Q1 2026 | $822.6M | 14.56M | — | — |
| Q4 2025 | $866M | 14.57M | — | — |
| Q3 2025 | $795.4M | 14.69M | — | — |
| Q2 2025 | $830.5M | 15.11M | — | — |
| Q1 2025 | $1.1B | 14.96M | — | — |
| Q4 2024 | $969.3M | 14.75M | — | — |
| Q3 2024 | $976.9M | 13.90M | — | — |
| Q2 2024 | $1.1B | 13.93M | — | — |
| Q1 2024 | $1.2B | 13.99M | — | — |
| Q4 2023 | $1.3B | 13.99M | — | — |
| Q4 2023 | $1.3B | 13.99M | — | — |
| Q3 2023 | $1.3B | 14.15M | — | — |
| Q2 2023 | $1.2B | 14.29M | — | — |
| Q1 2023 | $1.4B | 14.33M | — | — |
Other funds holding BMRN
$1.3B
$990.4M
$932.1M
$793.3M
$763.5M
$690.9M
Other DODGE & COX positions
JCI
$8.1BJohnson Controls International PLC
SCHW-PJ
$7.9BThe Charles Schwab Corp.
SCHW-PJ
$7.7BThe Charles Schwab Corp.
SCHW-PJ
$7.6BThe Charles Schwab Corp.
JCI
$7.5BJohnson Controls International PLC
JCI
$7.2BJohnson Controls International PLC
SCHW-PJ
$7.1BThe Charles Schwab Corp.
JCI
$7.1BJohnson Controls International PLC